Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123134) titled 'A Multicenter, Prospective, Observational Real-World Study on the Efficacy and Safety of Fluocinolone Acetonide, Hydroquinone and Tretinoin Cream in the Treatment of Moderate to Severe Melasm' on April 22.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The Affiliated Hospital of Chengde Medical University
Condition:
Melasma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-22
Target Sample Size: Observation group:1000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=319805
Published by HT Digi...